Self-Assessment Questions (SAQs) for Study Session 3

Now that you have completed this study session you can assess how well you have achieved its Learning Outcomes by answering the following questions. Some of the question test the Learning Outcomes for Study Session 2, as well as those for Study Session 3. Write your answers in your Study Diary and discuss them with your Tutor at the next Study Support Meeting. You can check your answers with the notes on the Self-Assessment Questions at the end of this Module.

SAQ 3.1 (tests Learning Outcomes 2.1, 2.2, 3.1 and 3.2)

Classify each of the following vaccines as either antibacterial or antiviral (or both) by putting crosses in the appropriate columns of Table 3.6. Write the name of the diseases or conditions that each vaccine prevents in the last column of the table.

Table 3.6  Antibacterial and antiviral vaccine characteristics.
VaccineAntibacterialAntiviralProtects against
BCG vaccine
Measles vaccine
Pentavalent vaccine
Yellow fever vaccine
Pneumococcal vaccine (PCV10)
OPV
TT vaccine
Meningococcal vaccine
Rotavirus vaccine

Answer

The completed version of Table 3.6 appears below.

Table 3.7  Antibacterial and antiviral vaccine characteristics.
VaccineAntibacterialAntiviralProtects against
BCG vaccineXTuberculosis
Measles vaccineXMeasles
Pentavalent vaccineX (four components)X (one component)Diphtheria, pertussis, tetanus, Haemophilus influenzae type b meningitis and pneumonia, hepatitis B liver diseases
Yellow fever vaccineXYellow fever
Pneumococcal vaccine (PCV10)XPneumococcal diseases (including pneumonia)
OPVXPoliomyelitis
TT vaccineXNeonatal tetanus (and tetanus in women)
Meningococcal vaccineXMeningococcal meningitis
Rotavirus vaccineXDiarrhoea and dehydration caused by rotaviruses

SAQ 3.2 (tests Learning Outcome 3.3)

Summarise the dosage, route of administration and schedule for each of the current antiviral EPI vaccines used in Ethiopia by completing Table 3.7.

Table 3.7  Summary of dosage, route and schedule for antiviral EPI vaccines.
VaccineDosage and routeSchedule
HepB (as part of pentavalent vaccine)
OPV
Measles

Answer

The completed version of Table 3.7 appears below.

Table 3.7  Summary of dosage, route and schedule for the antiviral EPI vaccines.
VaccineDosage and routeSchedule
HepB (as part of pentavalent vaccine)0.5 ml, three intramuscular injectionsAt 6, 10 and 14 weeks
OPV2 drops, four oral doses At birth, and 6, 10 and 14 weeks
Measles0.5 ml, one subcutaneous injection in the EPI, plus one campaign doseAt 9 months of age in the EPI; campaign dose after 12 months

SAQ 3.3 (tests Learning Outcome 3.4)

Complete Table 3.8 to indicate the possible adverse events following immunization with OPV and measles vaccines, and their management at Health Post level.

Table 3.8  Adverse events following OPV and measles immunization, and their management.
VaccineAdverse eventsManagement
OPV
Measles

Answer

The completed version of Table 3.8 appears below.

Table 3.8  Adverse events following OPV and measles immunization, and their management
VaccineAdverse eventsManagement
OPVNoneNone required
MeaslesMild rash Mild feverNone required Paracetamol syrup

SAQ 3.4 (tests Learning Outcomes 2.3 and 3.3)

What immunizations (if any) should the following children be given? Assume that rotavirus vaccine has not yet been introduced.

  • a.A newborn baby.
  • b.A ten-month-old child who has had BCG, OPV3, PCV3 and Penta3.
  • c.An eight-month-old child who has had BCG, OPV3, PCV3 and Penta3.
  • d.A six-week-old child who has had BCG and OPV0.

Answer

The immunizations (if any) that these individuals should receive are as follows:

  • a.A newborn baby should be given BCG and OPV0.
  • b.A ten-month-old child who has had BCG, OPV3, PCV3 and Penta3 should be given measles vaccine.
  • c.An eight-month-old child who has had BCG, OPV3, PCV3 and Penta3 should not be given any further vaccinations until he or she is 9 months old, when measles vaccine should be given.
  • d.A six-week-old child who has had BCG and OPV0 should be given OPV1, PCV1 and Penta1.

SAQ 3.5 (tests Learning Outcomes 2.5 and 3.5)

Fatima’s grandmother brings her to your Health Post when she is ten weeks old for OPV2, PCV2 and Penta2. Three days later, Fatima becomes very ill and develops a severe allergic reaction. After a brief period of hospitalisation, she recovers fully. When Fatima is 14 weeks old, her grandmother brings her to see you at an immunization clinic. She has a mild episode of diarrhoea at the time.

  • a.What vaccines (if any) should you give Fatima?
  • b.What should you explain to Fatima’s grandmother?

Answer

  • a.Immunize Fatima with OPV3; it is safe to give this vaccine even though she has mild diarrhoea. But do not give her PCV3 or Penta3 because she developed a severe allergic reaction three days after the earlier immunization, which may have been an adverse vaccine reaction following immunization with one of these vaccines. It is very unlikely to have been due to the previous dose of OPV.
  • b.Explain to the grandmother that it is safe for Fatima to have another dose of OPV, and why you are not giving the child another dose of the other two vaccines. Tell the grandmother to come back after another four weeks; because of the diarrhoea Fatima has today, she will need an extra (fifth) dose of OPV in four weeks’ time.

Summary of Study Session 3